ODI Pharma AB (publ) (NGM:ODI)
Sweden flag Sweden · Delayed Price · Currency is SEK
4.120
-0.040 (-0.96%)
At close: Mar 20, 2026

ODI Pharma AB Balance Sheet

Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
4.761.482.646.497.3614.62
Cash & Short-Term Investments
4.761.482.646.497.3614.62
Cash Growth
-11.16%-43.87%-59.28%-11.76%-49.69%-28.71%
Accounts Receivable
4.240.128.070.130.11-
Other Receivables
0.81.380.910.680.990.93
Receivables
5.041.498.980.811.090.93
Inventory
---0.811.431.05
Prepaid Expenses
0.120.630.590.06--
Other Current Assets
---00.60.26
Total Current Assets
9.923.6112.228.1810.4816.87
Property, Plant & Equipment
0.0100.010.010.010.01
Other Long-Term Assets
-10---
Total Assets
9.934.6112.238.1910.516.88
Accounts Payable
4.890.3950.710.670.15
Accrued Expenses
0.011.011.160.35--
Current Income Taxes Payable
-00.090--
Current Unearned Revenue
----0.550.4
Other Current Liabilities
3.092.793.984.540.010.04
Total Current Liabilities
84.1910.235.611.240.58
Total Liabilities
84.1910.235.611.240.58
Common Stock
0.730.640.610.610.610.61
Additional Paid-In Capital
27.0825.9621.8421.8421.8421.84
Comprehensive Income & Other
-25.87-26.17-20.45-19.88-13.19-6.15
Shareholders' Equity
1.930.4222.579.2616.3
Total Liabilities & Equity
9.934.6112.238.1910.516.88
Net Cash (Debt)
4.761.482.646.497.3614.62
Net Cash Growth
-11.16%-43.87%-59.28%-11.76%-49.69%-28.71%
Net Cash Per Share
0.240.080.170.420.490.95
Filing Date Shares Outstanding
18.3318.3315.2215.2215.2215.22
Total Common Shares Outstanding
18.3318.3315.2215.2215.2215.22
Working Capital
1.92-0.581.992.569.2516.29
Book Value Per Share
0.110.020.130.170.611.07
Tangible Book Value
1.930.4222.579.2616.3
Tangible Book Value Per Share
0.110.020.130.170.611.07
Machinery
-0.040.040.040.040.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.